{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:21:50Z","timestamp":1777573310032,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,8]]},"DOI":"10.7759\/cureus.32319","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T16:20:24Z","timestamp":1670516424000},"source":"Crossref","is-referenced-by-count":1,"title":["Tardive Dyskinesia Following Low-Dose Risperidone"],"prefix":"10.7759","author":[{"given":"Ahmad E","family":"Rokon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal A","family":"Alsomali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malek A","family":"Alrasheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman D","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustafa   S","family":"Alhamadh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmajeed M","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah K","family":"Alhamidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meshal R","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7916\/D8FF58Z9","article-title":"Tardive dyskinesia-like syndrome due to drugs that do not block dopamine receptors: rare or non-existent: literature review","volume":"8","author":"D'Abreu A","year":"2018","unstructured":"D'Abreu A, Friedman JH. Tardive dyskinesia-like syndrome due to drugs that do not block dopamine receptors: rare or non-existent: literature review. Tremor Other Hyperkinet Mov (N Y). 2018, 8:570. 10.7916\/D8FF58Z9","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0559-8","article-title":"Antipsychotic-associated symptoms of Tourette syndrome: a systematic review","volume":"32","author":"Kim DD","year":"2018","unstructured":"Kim DD, Barr AM, Chung Y, et al.. Antipsychotic-associated symptoms of Tourette syndrome: a systematic review. CNS Drugs. 2018, 32:917-38. 10.1007\/s40263-018-0559-8","journal-title":"CNS Drugs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787","article-title":"","author":"American Psychiatric Association","year":"2022","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Association, Virginia; 2022. 10.1176\/appi.books.9780890425787"},{"key":"ref4","article-title":"Antidepressant and antipsychotic prescribing in primary care for people with dementia","volume":"64","author":"Drummond N","year":"2018","unstructured":"Drummond N, McCleary L, Freiheit E, et al.. Antidepressant and antipsychotic prescribing in primary care for people with dementia. Can Fam Physician. 2018, 64:e488-97.","journal-title":"Can Fam Physician"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2045125318781475","article-title":"The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses","volume":"8","author":"Haddad PM","year":"2018","unstructured":"Haddad PM, Correll CU. The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses. Ther Adv Psychopharmacol. 2018, 8:303-18. 10.1177\/2045125318781475","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies","volume":"161","author":"Correll CU","year":"2004","unstructured":"Correll CU, Leucht S, Kane JM. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry. 2004, 161:414-25. 10.1176\/appi.ajp.161.3.414","journal-title":"Am J Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S196541","article-title":"Overcoming barriers to effective management of tardive dyskinesia","volume":"15","author":"Caroff SN","year":"2019","unstructured":"Caroff SN. Overcoming barriers to effective management of tardive dyskinesia. Neuropsychiatr Dis Treat. 2019, 15:785-94. 10.2147\/NDT.S196541","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref8","article-title":"Medication induced movement disorders","author":"Kaplan HI","year":"1995","unstructured":"Kaplan HI, Saddock B, Grebb JA. Medication induced movement disorders. Comprehensive Textbook of Psychiatry. Walters Kluwer, Alphen aan den Rijn, Netherlands; 1995. 1909-15."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1993.tb03326.x","article-title":"Persistent tardive dyskinesia: demographic and pharmacological risk factors","volume":"87","author":"Muscettola G","year":"1993","unstructured":"Muscettola G, Pampallona S, Barbato G, Casiello M, Bollini P. Persistent tardive dyskinesia: demographic and pharmacological risk factors. Acta Psychiatr Scand. 1993, 87:29-36. 10.1111\/j.1600-0447.1993.tb03326.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref10","article-title":"Multidose risperidone treatment evaluated in a rodent model of tardive dyskinesia","volume":"31","author":"Gao XM","year":"2005","unstructured":"Gao XM, Cooper T, Suckow R. Multidose risperidone treatment evaluated in a rodent model of tardive dyskinesia. Neuropsychopharmacol. 2005, 31:1864-8.","journal-title":"Neuropsychopharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1999.tb01595.x","article-title":"Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients","volume":"47","author":"Jeste DV","year":"1999","unstructured":"Jeste DV, Lacro JP, Bailey A, Rockwell E, Harris MJ, Caligiuri MP. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc. 1999, 47:716-9. 10.1111\/j.1532-5415.1999.tb01595.x","journal-title":"J Am Geriatr Soc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman JA","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, et al.. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005, 353:1209-23. 10.1056\/NEJMoa051688","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13306-5","article-title":"New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis","volume":"361","author":"Leucht S","year":"2003","unstructured":"Leucht S, Wahlbeck K, Hamann J, Kissling W. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet. 2003, 361:1581-9. 10.1016\/S0140-6736(03)13306-5","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.6.843a","article-title":"Tardive dyskinesia induced by risperidone?","volume":"153","author":"Woerner MG","year":"1996","unstructured":"Woerner MG, Sheitman BB, Lieberman JA, Kane JM. Tardive dyskinesia induced by risperidone?. Am J Psychiatry. 1996, 153:843a-843. 10.1176\/ajp.153.6.843a","journal-title":"Am J Psychiatry"},{"key":"ref15","article-title":"Risperidone induced tardive dyskinesia","volume":"153","author":"Buzan RD","year":"1996","unstructured":"Buzan RD. Risperidone induced tardive dyskinesia. Am J Psychiatry. 1996, 153:734-5.","journal-title":"Am J Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.12.2016","article-title":"Reduction of tardive dystonia with olanzapine","volume":"156","author":"Jaffe ME","year":"1999","unstructured":"Jaffe ME, Simpson GM. Reduction of tardive dystonia with olanzapine. Am J Psychiatry. 1999, 156:2016. 10.1176\/ajp.156.12.2016","journal-title":"Am J Psychiatry"},{"key":"ref17","article-title":"Risperidone induced tardive dyskinesia - a case report","volume":"44","author":"Vasudevan OV","year":"2002","unstructured":"Vasudevan OV, Pinto DA, Gopinath PS. Risperidone induced tardive dyskinesia - a case report. Indian J Psychiatry. 2002, 44:384-6.","journal-title":"Indian J Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.76.895.316","article-title":"Risperidone implicated in the onset of tardive dyskinesia in a young woman","volume":"76","author":"Kumar S","year":"2000","unstructured":"Kumar S, Malone DM. Risperidone implicated in the onset of tardive dyskinesia in a young woman. Postgrad Med J. 2000, 76:316-7. 10.1136\/pmj.76.895.316","journal-title":"Postgrad Med J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.11.1948","article-title":"Tardive dyskinesia with risperidone and anticholinergics","volume":"159","author":"Suzuki E","year":"2002","unstructured":"Suzuki E, Obata M, Yoshida Y, Miyaoka H. Tardive dyskinesia with risperidone and anticholinergics. Am J Psychiatry. 2002, 159:1948. 10.1176\/appi.ajp.159.11.1948","journal-title":"Am J Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.5.734a","article-title":"Neuroleptic-induced tardive dyskinesia","volume":"153","author":"Daniel DG","year":"1996","unstructured":"Daniel DG, Smith K, Hyde T, Egan M. Neuroleptic-induced tardive dyskinesia. Am J Psychiatry. 1996, 153:734. 10.1176\/ajp.153.5.734a","journal-title":"Am J Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979301","article-title":"Risperidone-induced tardive dyskinesia","volume":"31","author":"Silberbauer C","year":"1998","unstructured":"Silberbauer C. Risperidone-induced tardive dyskinesia. Pharmacopsychiatry. 1998, 31:68-9. 10.1055\/s-2007-979301","journal-title":"Pharmacopsychiatry"},{"key":"ref22","article-title":"Severe tardive dyskinesia during treatment with risperidone and fluoxetine [Article in Dutch]","volume":"142","author":"Dubbelman YD","year":"1998","unstructured":"Dubbelman YD, Thung FH, Heeringa M. Severe tardive dyskinesia during treatment with risperidone and fluoxetine [Article in Dutch]. Ned Tijdschr Geneeskd. 1998, 142:1508-11.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.8.1290","article-title":"Risperidone-induced tardive dyskinesia","volume":"156","author":"Hong KS","year":"1999","unstructured":"Hong KS, Cheong SS, Woo JM, Kim E. Risperidone-induced tardive dyskinesia. Am J Psychiatry. 1999, 156:1290. 10.1176\/ajp.156.8.1290","journal-title":"Am J Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/125243-tardive-dyskinesia-following-low-dose-risperidone","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:27Z","timestamp":1707507807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/125243-tardive-dyskinesia-following-low-dose-risperidone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.32319","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,8]]}}}